The EESC welcomes the overall positive trade balance of the EU and calls for measures to maintain it, while recommending targeted support for strategically important industries, stronger investment conditions, and effective financing through the Single Market, the Savings and Investments Union, and a more integrated capital market. The EESC also underlines the need to support ambitious companies entering global markets, ensure opportunities for highly skilled professionals, simplify procedures without undermining social and environmental standards, create fiscal space for growth-enhancing investments, and strengthen multilateralism through new trade agreements and WTO reforms.
The EESC supports the objectives of the Commission's package on securitisation, and recommends to ensure that the freed-up capital is used to fund the real economy, introduce safeguards for consumers and investors, guarantee financial stability, and avoid weakening, to the extent possible, international standards.
Among the measures to make it possible, the EESC recommends a two-years reporting period, the introduction of a fast-track mechanism, taking additional measures to preserve the long-term relationship between lenders and borrowers, and introducing social, environmental and governance information in the revised reporting templates.
The opinion focuses on the legislative proposals package "Omnibus IV" whose measures aim at cutting red tape for small-mid caps and modernising EU rules as regards digitalisation and common specifications.
Clean technologies are projected to continue expanding in turnover, investments and jobs. Thanks to ambitious climate targets, the EU is a global leader in high-value inventions and was an early mover in developing a cleantech production base. However, it has lost technological leadership in several sectors and its manufacturing base is eroding.
This exploratory opinion, requested by the Danish Presidency, outlines how AI and Big Data can improve rare disease patient pathways and support the development of personalised treatments. It highlights the main challenges linked to their use, such as data privacy, algorithmic bias, affordability, and geographical accessibility. In the text, the EESC puts forward recommendations to ensure that these technologies are applied in an ethical, inclusive, and patient-centred way.
